DocGo Inc (DCGO)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $20.55M
Last updated: Nov 17, 2026 at 4:10 PM ET
DocGo Inc (DCGO) Statistics
DocGo (DCGO) has a market cap of $20.55M and an enterprise value of $12.52M. It kept -65.69% of revenue as net income over the last 12 months. It holds $8.03M more cash than debt, 39.10% of its market cap.
Total Valuation
Enterprise value is 39.10% below the market cap, as cash exceeds debt.
| Market Cap | $20.55M |
|---|---|
| Enterprise Value | $12.52M |
| Latest price (Nov 17, 2026) | $0.18 |
Key Dates
The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 15, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 0.2x |
|---|---|
| P/TBV Ratio | 0.2x |
Price Statistics
The stock is down 82.88% over 52 weeks and trades 40.00% below its 50-day average.
| Beta (1Y) | 1.66 |
|---|---|
| 52-Week Change | -82.88% |
| 1-Month Change | -28.13% |
| 3-Month Change | -56.43% |
| 6-Month Change | -67.67% |
| Total Return (1Y) | -82.88% |
| Total Return (3Y CAGR) | -68.38% |
| Total Return (5Y CAGR) | -54.97% |
| Max Drawdown (1Y) | -83.04% |
| Max Drawdown (3Y) | -97.03% |
| Sharpe Ratio (1Y) | -1.81 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $0.30 |
| 200-Day Average | $0.54 |
| 52-Week Range | $0.18 to $1.10 |
| RSI (14 Days) | 28.8 |
| Average Volume (20 Days) | 806.79K |
Financial Position
Current assets cover 1.38x current liabilities, and total debt is 0.11x shareholder equity.
| Current Ratio | 1.38x |
|---|---|
| Quick Ratio | 1.38x |
| Debt / Equity | 0.11x |
Returns and Efficiency
Return on invested capital is -140.82% over the last 12 months, against a 5-year average of -20.13%.
| Return on Equity (ROE) | -185.87% |
|---|---|
| Return on Assets (ROA) | -112.32% |
| Return on Invested Capital (ROIC) | -140.82% |
| Return on Capital Employed (ROCE) | -173.56% |
| ROE (5Y Average) | -21.77% |
| ROA (5Y Average) | -14.29% |
| ROIC (5Y Average) | -20.13% |
| Asset Turnover | 1.13x |
| Receivables Turnover | 3.51x |
Scores
DCGO has an Altman Z-Score of -2.93, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -2.93 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $297.34M over the last 12 months is down 19.22% from the 12 months before.
| Revenue | $297.34M |
|---|---|
| Revenue Growth (YoY) | -19.22% |
| Gross Profit | $73.90M |
| Operating Income | -$158.50M |
| Pretax Income | -$164.44M |
| Net Income | -$195.32M |
| EBITDA | -$152.03M |
| EBIT | -$163.58M |
| Reported EPS (TTM) | -$2.02 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 60.43% of the $173.90M in total assets.
| Cash and Equivalents | $19.11M |
|---|---|
| Total Debt | $11.07M |
| Net Cash | $8.03M |
| Net Cash Per Share | $0.08 |
| Working Capital | $30.05M |
| Shareholder Equity | $105.08M |
| Book Value Per Share | $1.06 |
| Tangible Book Value | $103.19M |
| Tangible Book Per Share | $1.04 |
| Total Assets | $173.90M |
| Total Liabilities | $94.92M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $4.41M of capital spending, operating cash flow left -$32.40M of free cash flow.
| Operating Cash Flow | -$27.99M |
|---|---|
| Capital Expenditures | $4.41M |
| Free Cash Flow | -$32.40M |
| FCF Per Share | -$0.33 |
| Depreciation and Amortization | $11.54M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -53.30%, against a 5-year average of -7.68%.
| Gross Margin | 24.85% |
|---|---|
| Operating Margin | -53.30% |
| Pretax Margin | -55.30% |
| Net Margin | -65.69% |
| EBITDA Margin | -51.13% |
| EBIT Margin | -55.01% |
| FCF Margin | -10.90% |
| Gross Margin (5Y Average) | 33.23% |
| Operating Margin (5Y Average) | -7.68% |
| Net Margin (5Y Average) | -8.83% |
Growth
Revenue fell 9.90% a year over 3 years.
| Revenue Growth (3Y CAGR) | -9.90% |
|---|---|
| Revenue Growth (5Y CAGR) | +27.91% |
| FCF Growth (3Y CAGR) | +5.22% |
| Book Value Per Share Growth (2Y CAGR) | -28.17% |
| Tangible Book Per Share Growth (2Y CAGR) | -15.15% |
Dividends and Yields
DCGO does not pay a dividend. Its free cash flow yield is -178.75%.
| FCF Yield | -178.75% |
|---|---|
| Buyback Yield | 0.00% |
Peer Position
Against 9 similar companies, DCGO has the lowest ROIC.
ROICPeer median 1.15%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.87%
| ROIC | -140.82% vs 1.15% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -19.22% vs +10.87% median |
Analyst Forecast
Consensus estimates put revenue growth at -2.05% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -2.05% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About DCGO
What is DCGO's market cap?
DocGo has a market cap of $20.55M. Its enterprise value, which adds debt and subtracts cash, is $12.52M.
How many shares of DCGO are outstanding?
DocGo has 98.94M shares outstanding. The count is up 1.16% from a year earlier.
Does DCGO pay a dividend?
No. DocGo does not pay a dividend.
How much debt does DCGO have?
DocGo has $11.07M of total debt and $19.11M of cash and equivalents, a net cash position of $8.03M.
DCGO pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors